Recent data have shown that coagulation activation is common in patients with severe COVID-19. Moreover, autopsy studies have reported widespread microthrombi disseminated throughout the pulmonary vasculature, suggesting that vasculopathy is important in COVID-19 pathogenesis. These post-mortem studies have also highlighted substantial endothelial cell damage, with evidence of apoptosis and loss of tight junctions. Collectively, these data suggest that endothelial cells play a key role in orchestrating the unusual pulmonary intravascular coagulopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.</p
Background: Infection by SARS-CoV-2 produces significant pulmonary pathology including endothelial d...
COVID-19 management guidelines have largely attributed critically ill patients who develop acute res...
The novel coronavirus infectious disease (COVID-19) has rapidly spread and poses a great challenge t...
Recent data have shown that coagulation activation is common in patients with severe COVID-19. Moreo...
Endothelial cell (EC) dysfunction is a characteristic complication of coronavirus-19 (COVID-19). Thi...
Rationale: Autopsy and biomarker studies suggest that endotheliopathy contributes to coronavirus dis...
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new strain of a Coronaviridae virus ...
Understanding of the clinical, histological and molecular features of the novel coronavirus 2019 (Se...
Background: Severe COVID-19 is associated with marked endothelial cell (EC) activation that plays a ...
The world is in a hard battle against COVID-19. Endothelial cells are among the most critical target...
The endothelium has a fundamental role in the cardiovascular complications of coronavirus disease 20...
In severe SARS-CoV-2 infections, emerging data including recent histopathological studies have empha...
The pulmonary endothelium is a highly regulated organ that performs a wide range of functions under ...
The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or...
Background: Infection by SARS-CoV-2 produces significant pulmonary pathology including endothelial d...
COVID-19 management guidelines have largely attributed critically ill patients who develop acute res...
The novel coronavirus infectious disease (COVID-19) has rapidly spread and poses a great challenge t...
Recent data have shown that coagulation activation is common in patients with severe COVID-19. Moreo...
Endothelial cell (EC) dysfunction is a characteristic complication of coronavirus-19 (COVID-19). Thi...
Rationale: Autopsy and biomarker studies suggest that endotheliopathy contributes to coronavirus dis...
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new strain of a Coronaviridae virus ...
Understanding of the clinical, histological and molecular features of the novel coronavirus 2019 (Se...
Background: Severe COVID-19 is associated with marked endothelial cell (EC) activation that plays a ...
The world is in a hard battle against COVID-19. Endothelial cells are among the most critical target...
The endothelium has a fundamental role in the cardiovascular complications of coronavirus disease 20...
In severe SARS-CoV-2 infections, emerging data including recent histopathological studies have empha...
The pulmonary endothelium is a highly regulated organ that performs a wide range of functions under ...
The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or...
Background: Infection by SARS-CoV-2 produces significant pulmonary pathology including endothelial d...
COVID-19 management guidelines have largely attributed critically ill patients who develop acute res...
The novel coronavirus infectious disease (COVID-19) has rapidly spread and poses a great challenge t...